Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 10

QUALITY CONTROL P.

2
DIAGNOSTIC TEST CUMULATIVE SUM GRAPH (CUSUM)

QC Result

Patient result

• Calculates the difference between QC results and


target means
QUALITY CONTROL CHARTS
• Common method: V mask
1. Gaussian Curve ( Bell- Shaped Curve)
• Identifies consistent bias problems; requires
2. Cumulative Sum graph
computer implementation
3. Youden Twin Plot
• This plot will give the earliest indication of
4. Shewart Levey Jennings Chart
systematic errors (trend) and can be used with
the 13s rule
• Results are out of control when the slope exceeds
GAUSSIAN CURVE
4S or a decision (±2SD) is exceeded.

YOUDEN/ TWIN PLOT

• Occurs when the data set can be accurately


described by the SD & the mean
• Obtained by plotting the values from multiple
analyses of samples
• Population probability distribution that is
symmetric about the mean
• It focuses on the distribution of errors from the
• Used to compare results obtained on a high and
analytical method rather than the values from a
low control serum from different laboratories
healthy or patient population
• are a graphical technique for analyzing interlab
• The total area under the curve is 1.0 or 100%
data when each lab has made two runs on the
same product or one run on two different
products.
QUALITY CONTROL P.2
SHEWART LEVEY-JENNINGS CHART
Why establish own QC Ranges?
1. Assign target values and ranges for an unassayed
control
2. Improve accuracy of target values and ranges
3. Improve stringency of acceptable limits
4. To meet regulatory requirements

Steps in Establishing QC Reference ranges?


1. Establishing Mean Target Values using Parallel
Testing
2. Calculating Historical CV (CVh)
3. Determining Appropriateness of Calculated CVh
4. Establishing QC Ranges using CVh

STEP 1:
 Most widey used QC chart in the clinical Establishing Mean Target Values Using Parallel
laboratory Testing
 Allows the laboratorians to apply multiple rules
without the aid of a computer’ it is a graphic Parallel Testing is the name given to running the
representation of the acceptable limits of current QC lot and a new QC lot in tandem.
variation in the results of an analytical method. • To perform Parallel Testing:
 It easily identifies random and systematic errors 1. The new QC lot should then be analysed 2-3
times daily for approximately 10 days,
OPERATION OF A QC SYTSTEM ensuring that at least 20 data points are
The QC program can be thought of as a three-stage generated.
process: 2. Review the data generated to ensure that
1. Establishing allowable statistical limits of assay precision (CV) is lower than the CV
variation for each analytic method obtained in the manufacturer’s
2. Using these limits as criteria for evaluating the specifications.
QC data generated for each test 3. Calculate the Mean and Standard Deviation
3. Taking action to remedy errors when indicated (SD) for each analyte.
a) Finding the cause(s) of error
b) Taking corrective action
c) Reanalyzing control and patient data STEP 2:
Establishing Historical CV (CVh)
Establishment of a Statistical Quality Control
New instrument or with new lots of control material: • CVh
 control material must be analyzed for 20 days.  the historical instrument precision for that
Exceptions: method measured as a percent
Machines that are highly precise (%CV = SD/Mean X 100)
(CV < 1%),  best established over several lots (3 or more)
Eg. blood gases: 5 days is adequate  average CV or more preferable
 the highest acceptable CV over that period.
 If you have no previous CV data, then use the
current CV as the CVh basis increase slightly
(~1- 2%) in order to establish QC ranges that
are not too narrow.
 The calculated CVh should not exceed the
instrument-method CV provided by the
manufacturer(3).
 The CVh should not exceed the average
assay-specific CV provided by EQA schemes.
EQA schemes (e.g. RIQAS)
QUALITY CONTROL P.2
STEP 3:
Establishing QC Ranges using CVh

• Parallel testing
• Calculate CV
• Calculate the SD
• Assigning Reference range

Assign the Reference range

Levey- Jennings Charts


& Westgard Rules

Comparison of Quality Control Results


QUALITY CONTROL P.2
Create a Levey Jennings chart using a mean of 90 U/L Causes of trending may include:
& SD: 9 U/L  Deterioration of the instrument light source
Assume that each data point was obtained on  Gradual accumulation of debris in
separate days. sample/reagent tubing
Are the points outside the ±2s limit?  Gradual accumulation of debris on electrode
Level I (Normal Control) surfaces
Unassayed Chemistry Control  Aging of reagents
Lot No. 12345  Gradual deterioration of control materials
Test: Creatine Kinase  Gradual deterioration of incubation chamber
Instrument: ABC temperature (enzymes only)
Units: U/L  Gradual deterioration of light filter integrity
Control Values are:  Gradual deterioration of calibration
{94, 93, 97, 95, 95, 100, 100, 99, 100, 99}

Shift
• Abrupt changes in the control mean
• Shifts in QC data represent a sudden and
dramatic positive or negative change in test
system performance

Shifts may be caused by:

Using a Levey-Jennings Chart


to Evaluate Run Quality
• Maintaining a QC Log and using the Levey-
Jennings chart on a regular basis.
QC log
• can be maintained on a computeror on paper.
• should identify :
 name of the test, the instrument, units
 the date the test is performed
 the initials of the person performing the test,
 the results for each level of control assayed
Systematic Error
• The change in the mean may be gradual and
demonstrated as a trend in control values or it
may be abrupt and demonstrated as a shift in
control values.
Trend
• Indicates a gradual loss of reliability in the test
system. Trends are usually subtle.
QUALITY CONTROL P.2
Westgard Rules
• Dr. James Westgard of the University of
Wisconsin
 Published an article on laboratory quality
control that set the basis for evaluating
analytical run quality for medical laboratories.
 devised a shorthand notation for expressing
quality control rules
 N represents the number of control
observations to be evaluated and
 L represents the statistical limit for evaluating
the control observations.

OUTLIERS
• Are control values that are far from the main set
of values
• Caused by systematic and random errors
• They are highly deviating values  This is a warning rule that is violated when a
single control observation is outside the ±2s
limits.
 This rule merely warns that random error or
systematic error may be present in the test
system.
 The relationship between this value and other
control results within the current and previous
analytical runs must be examined.
 If no relationship can be found and no source of
error can be identified, it must be assumed that a
single control value outside the ±2s limits is an
acceptable random error.
Random Error  Patient results can be reported
• Is any deviation away from an expected result.
• There is acceptable (or expected) random error as
defined and quantified by standard deviation.
• There is unacceptable (unexpected) random error
that is any data point outside the expected
population of data (e.g., a data point outside the
±3s limits).
QUALITY CONTROL P.2

• This rule identifies random error only, and is


applied only within the current run
• At least a 4s difference between control values
within a single run, the rule is violated for random
error
• Violation of any of the following rules does not
necessarily require rejection of the analytical
run.
• These violations typically identify smaller
systematic error or analytical bias that is not
often clinically significant or relevant.
QUALITY CONTROL P.2
QUALITY CONTROL P.2
QUALITY CONTROL P.2

Additional Quality Control Statistics

The Coefficient of Variation [CV]


 Is the ratio of the standard deviation to the
mean and is expressed as a percentage.
 Allows the technologist to make easier
comparisons of the overall precision.
 statistical equalizer
QUALITY CONTROL P.2

Coefficient of Variation Ratio [CVR] Selecting a Control Product


• Although accuracy of test results is paramount in
the clinical laboratory, precision is just as Shelf Life
important.  Your quality control shelf life should match or
• One way a laboratory can determine whether the exceed the laboratory’s normal usage rate or
precision of a specific test is acceptable is to money will be wasted
compare its precision to that of another Box Pricing
laboratory performing the same test on the same  Always ask for quality control product quotes on a
instrument using the same reagents (laboratory per mL basis and not box price.
peer group). Clinical Relevant Decision Levels
 It requires the laboratory to compare the relevant
Standard Deviation Index [SDI]
clinical levels for each test to those provided in
the quality control product
Interlaboratory Comparison Programs
 One of the easiest methods to assess reliability
and imprecision is to compare the within-
laboratory method means and standard
deviations to other laboratories using the same
instrument and method (peer group).

You might also like